Saba Capital Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Saba Capital Management’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-205,512	Closed	-$2.12M	–	608
2023 Q2	$2.12M	Hold	205,512	–	–	0.06%	223
2023 Q1	$2.13M	Sell	205,512 -1,083,586	-84%	-$11M	0.04%	332
2022 Q4	$12.9M	Hold	1,289,098	–	–	0.18%	189
2022 Q3	$12.7M	Hold	1,289,098	–	–	0.14%	252
2022 Q2	$12.6M	Buy	1,289,098 +88,758	+7%	+$868K	0.15%	235
2022 Q1	$11.7M	Buy	1,200,340 +207,500	+21%	+$2.02M	0.17%	187
2021 Q4	$9.65M	Hold	992,840	–	–	0.15%	197
2021 Q3	$9.63M	Buy	992,840 +402,076	+68%	+$3.9M	0.24%	102
2021 Q2	$5.73M	Buy	+590,764	New	+$5.78M	0.16%	138

Other funds holding AONC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Saba Capital Management's AONC Position: Q3 2023 in Review

Saba Capital Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q3 2023, closing a stake of 205,512 shares — an estimated $2.12M sold.

Saba Capital Management first reported a position in AONC in Q2 2021 and held it in 9 quarters. The position peaked at $12.9M in Q4 2022. 3 funds tracked by Wall St. Rank hold AONC as of Q3 2023.

Saba Capital Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Saba Capital Management sold 205,512 American Oncology Network, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.12M.
Saba Capital Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 9 quarters.
Saba Capital Management's American Oncology Network, Inc. Class A Common Stock position peaked at $12.9M in Q4 2022.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q3 2023.

Based on Saba Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.